APA (7th ed.) Citation

Harada, N., Shibata, W., Koh, H., Takashita, E., Fujisaki, S., Okamura, H., . . . Kakeya, H. (2020). Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: A case report. BMC infectious diseases, 20(1), 1-5. https://doi.org/10.1186/s12879-020-05205-1

Chicago Style (17th ed.) Citation

Harada, Naonori, et al. "Successful Treatment with Baloxavir Marboxil of a Patient with Peramivir-resistant Influenza A/H3N2 with a Dual E119D/R292K Substitution After Allogeneic Hematopoietic Cell Transplantation: A Case Report." BMC Infectious Diseases 20, no. 1 (2020): 1-5. https://doi.org/10.1186/s12879-020-05205-1.

MLA (9th ed.) Citation

Harada, Naonori, et al. "Successful Treatment with Baloxavir Marboxil of a Patient with Peramivir-resistant Influenza A/H3N2 with a Dual E119D/R292K Substitution After Allogeneic Hematopoietic Cell Transplantation: A Case Report." BMC Infectious Diseases, vol. 20, no. 1, 2020, pp. 1-5, https://doi.org/10.1186/s12879-020-05205-1.